244 related articles for article (PubMed ID: 11322351)
1. Safety of electrical cardioversion in patients with previous embolic events.
Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB
Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351
[TBL] [Abstract][Full Text] [Related]
2. Incidence of spontaneous echocontrast, 'sludge' and thrombi before cardioversion in patients with atrial fibrillation: new insights into the role of transesophageal echocardiography.
Maltagliati A; Galli CA; Tamborini G; Celeste F; Muratori M; Pepi M
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):523-8. PubMed ID: 19474574
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic complications after electrical cardioversion in patients with atrial flutter.
Elhendy A; Gentile F; Khandheria BK; Gersh BJ; Bailey KR; Montgomery SC; Seward JB; Tajik AJ
Am J Med; 2001 Oct; 111(6):433-8. PubMed ID: 11690567
[TBL] [Abstract][Full Text] [Related]
4. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
5. Safety of electrical cardioversion in patients with atrial fibrillation.
Gentile F; Elhendy A; Khandheria BK; Seward JB; Lohse CM; Shen WK; Bailey KR; Montgomery SC; Burger KN; Tajik AJ
Mayo Clin Proc; 2002 Sep; 77(9):897-904. PubMed ID: 12233921
[TBL] [Abstract][Full Text] [Related]
6. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience.
Corrado G; Santarone M; Beretta S; Tadeo G; Tagliagambe LM; Foglia-Manzillo G; Spata M; Miglierina E; Acquati F; Santarone M
Europace; 2000 Apr; 2(2):119-26. PubMed ID: 11225938
[TBL] [Abstract][Full Text] [Related]
7. Improved Ventricular Function after TEE-guided Cardioversion of Atrial Arrhythmias in Patients after the Fontan Operation.
Poterucha JT; Egbe AC; Johnson JN; Niaz T; Wackel PL; Cannon BC; Eidem BW; Cetta F
Congenit Heart Dis; 2016 Dec; 11(6):578-583. PubMed ID: 27030521
[TBL] [Abstract][Full Text] [Related]
8. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
Kinch JW; Davidoff R
Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
[TBL] [Abstract][Full Text] [Related]
9. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
[TBL] [Abstract][Full Text] [Related]
10. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events.
Grimm RA; Stewart WJ; Arheart K; Thomas JD; Klein AL
J Am Coll Cardiol; 1997 Mar; 29(3):582-9. PubMed ID: 9060897
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography.
Mehta D; Baruch L
Chest; 1996 Oct; 110(4):1001-3. PubMed ID: 8874259
[TBL] [Abstract][Full Text] [Related]
13. Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.
Wu LA; Chandrasekaran K; Friedman PA; Ammash NM; Ramakrishna G; Hart CY; Moon BS; Herges RM; Rosales AG; Malouf JF
Am J Med; 2006 Feb; 119(2):142-6. PubMed ID: 16443416
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of transoesophageal echocardiography before cardioversion in patients with atrial fibrillation and different anticoagulant regimens.
Maltagliati A; Galli CA; Tamborini G; Calligaris A; Doria E; Salehi R; Pepi M
Heart; 2006 Jul; 92(7):933-8. PubMed ID: 16284221
[TBL] [Abstract][Full Text] [Related]
15. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials.
Moreyra E; Finkelhor RS; Cebul RD
Am Heart J; 1995 Jan; 129(1):71-5. PubMed ID: 7817928
[TBL] [Abstract][Full Text] [Related]
16. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS
J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133
[TBL] [Abstract][Full Text] [Related]
17. Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter.
Yadlapati A; Groh C; Passman R
Am J Cardiol; 2014 Apr; 113(8):1362-3. PubMed ID: 24576547
[TBL] [Abstract][Full Text] [Related]
18. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
de Luca I; Sorino M; Del Salvatore B; de Luca L
Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
[TBL] [Abstract][Full Text] [Related]
19. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion.
Gallagher MM; Hennessy BJ; Edvardsson N; Hart CM; Shannon MS; Obel OA; Al-Saady NM; Camm AJ
J Am Coll Cardiol; 2002 Sep; 40(5):926-33. PubMed ID: 12225717
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
